MYO Bathi resik saben saham (EPS TTM) Myomo Inc

Robotic arm exoskeletons provide Myomo, Inc. (MYO) with a steady cash flow and high market resilience. The company's 12-month unit profit level demonstrates fundamental business strength, while -0.35 reflects the metric's latest value. Revenues are based on the sale of MyoPro systems for motor recovery, and patented rehabilitation technologies create constant demand for ancillary services.

For Myomo, Inc., a leader in the development of myoelectric exoskeletons, this indicator reflects the efficiency of monetizing its technological superiority. The metric measures the net income per share annually, excluding the impact of equity dilution. By analyzing the rolling net income per share, an investor assesses the real return on sales. This allows for a comparison of R&D expenditures against actual profitability. The trend confirms the resilience of the innovator's business model.